Select a metric from the list below to chart it
Metric | Jan '19 | Jan '20 | Jan '21 | Jan '22 | Jan '23 | LTM |
---|---|---|---|---|---|---|
Total Revenues | 96.7 | 264.7 | 592.0 | 1,219.3 | 2,065.7 | 2,620.8 |
Total Revenues % Chg. | — | 173.9% | 123.6% | 106.0% | 69.4% | 40.9% |
Cost of Goods Sold, Total | 51.8 | 116.6 | 242.6 | 458.4 | 717.5 | 862.4 |
Gross Profit | 44.9 | 148.2 | 349.5 | 760.9 | 1,348.1 | 1,758.4 |
Selling General & Admin Expenses, Total | 161.7 | 401.1 | 655.5 | 1,009.0 | 1,397.0 | 1,646.5 |
R&D Expenses | 68.7 | 105.2 | 237.9 | 466.9 | 788.1 | 1,158.5 |
Other Operating Expenses, Total | 230.4 | 506.3 | 893.4 | 1,475.9 | 2,185.1 | 2,805.0 |
Operating Income | -185.5 | -358.1 | -543.9 | -715.0 | -837.0 | -1,046.6 |
Interest And Investment Income | 8.8 | 11.6 | 7.5 | 9.1 | 73.8 | 182.4 |
Net Interest Expenses | 8.8 | 11.6 | 7.5 | 9.1 | 73.8 | 182.4 |
Currency Exchange Gains (Loss) | — | -1.0 | -0.6 | 1.3 | -1.1 | -5.3 |
Other Non Operating Income (Expenses) | -0.5 | — | — | — | — | — |
EBT, Excl. Unusual Items | -177.2 | -347.5 | -537.0 | -704.6 | -764.3 | -869.5 |
Merger & Related Restructuring Charges | — | — | — | — | -5.3 | -5.3 |
Gain (Loss) On Sale Of Investments | — | — | — | 27.6 | -46.4 | -0.2 |
Asset Writedown | — | — | — | — | — | -7.1 |
EBT, Incl. Unusual Items | -177.2 | -347.5 | -537.0 | -677.0 | -816.0 | -882.1 |
Income Tax Expense | 0.8 | 1.0 | 2.1 | 3.0 | -18.5 | -6.6 |
Earnings From Continuing Operations | -178.0 | -348.5 | -539.1 | -679.9 | -797.5 | -875.6 |
Minority Interest | — | — | — | — | 0.8 | 1.6 |
Net Income | -178.0 | -348.5 | -539.1 | -679.9 | -796.7 | -873.9 |
Net Income to Common Incl Extra Items | -178.0 | -348.5 | -539.1 | -679.9 | -796.7 | -873.9 |
Net Income to Common Excl. Extra Items | -178.0 | -348.5 | -539.1 | -679.9 | -796.7 | -873.9 |
Total Shares Outstanding | 38.2 | 55.5 | 287.9 | 312.4 | 323.3 | 329.2 |
Weighted Avg. Shares Outstanding | 38.2 | 44.8 | 141.6 | 300.3 | 318.7 | 325.7 |
Weighted Avg. Shares Outstanding Dil | 38.2 | 44.8 | 141.6 | 300.3 | 318.7 | 325.7 |
EPS | -4.7 | -7.8 | -3.8 | -2.3 | -2.5 | -2.7 |
EPS Diluted | -4.7 | -7.8 | -3.8 | -2.3 | -2.5 | -2.7 |
EBITDA | -184.1 | -354.6 | -537.0 | -697.7 | -783.6 | -957.7 |